BRIEF-Guizhou Xinbang Pharmaceutical sees FY 2018 H1 net profit up 20 pct to 50 pct - What Are The Most Important Features To Look For In A New Haven Apartment?
15540
post-template-default,single,single-post,postid-15540,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-theme-ver-11.0,qode-theme-bridge,wpb-js-composer js-comp-ver-5.1.1,vc_responsive
 

BRIEF-Guizhou Xinbang Pharmaceutical sees FY 2018 H1 net profit up 20 pct to 50 pct

BRIEF-Guizhou Xinbang Pharmaceutical sees FY 2018 H1 net profit up 20 pct to 50 pct

April 23 (Reuters) – Guizhou Xinbang Pharmaceutical Co Ltd

* Says it sees FY 2018 H1 net profit to increase by 20 percent to 50 percent, or to be 175.8 million yuan to 219.8 million yuan

* Says FY 2017 H1 net profit was 146.5 million yuan

* Comments that inclusion of new companies and increased profit of pharmacy and circulation business as main reasons for the forecast

Source text in Chinese:goo.gl/Vcagqy

Further company coverage: (Beijing Headline News)

Source Article